Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Arteries of the Lower Limbs01:24

Arteries of the Lower Limbs

182
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
182
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

480
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
480
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

310
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
310
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

158
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
158
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

371
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
371
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

357
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
357

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomarkers for Diagnosing Ventilator Associated Pneumonia: Is that the Way Forward?

Indian journal of pediatrics·2018
Same author

Cross-Reactivity of Prokaryotic 16S rDNA-Specific Primers to Eukaryotic DNA: Mistaken Microbial Community Profiling in Environmental Samples.

Current microbiology·2018
Same author

Role of nm23H1 in predicting metastases in prostatic carcinoma.

Indian journal of pathology & microbiology·2018
Same author

The SbcC and SbcD homologs of the cyanobacterium Anabaena sp. strain PCC7120 (Alr3988 and All4463) contribute independently to DNA repair.

Functional & integrative genomics·2018
Same author

Surgical management of endobronchial hamartoma.

Lung India : official organ of Indian Chest Society·2018
Same author

Letter to the Editor concerning "Pilon fractures: A new classification system based on CT-scan" by Danilo Leonetti, *, Domenico Tigani (2017). Injury. 2017 Oct;48(10):2311-2317.

Injury·2018

Related Experiment Video

Updated: Jun 19, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.0K

TREADS: Target Research for Anti-epileptic Drugs Using Data Science.

Janaki Chintalapati1, Arvind Kumar1, M V Hosur2

  • 1C-DAC Knowledge Park, No.1, Old Madras Road, Byapanahalli, Bangalore, Karnataka, India.

Neurology India
|July 23, 2024
PubMed
Summary

Epilepsy research is enhanced by TREADS, a new platform integrating scattered data and providing machine learning tools to study anti-epileptic drug targets. This resource aids researchers in understanding epilepsy-associated proteins and drug development.

More Related Videos

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
10:46

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery

Published on: September 1, 2023

2.9K
Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
08:43

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Published on: July 21, 2015

25.6K

Related Experiment Videos

Last Updated: Jun 19, 2025

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.0K
Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery
10:46

Author Spotlight: Obtaining High-Quality CSF and Blood Samples for Epilepsy Biomarker Discovery

Published on: September 1, 2023

2.9K
Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System
08:43

Long-term Continuous EEG Monitoring in Small Rodent Models of Human Disease Using the Epoch Wireless Transmitter System

Published on: July 21, 2015

25.6K

Area of Science:

  • Neurology
  • Bioinformatics
  • Pharmacology

Background:

  • Epilepsy is a neurological disorder with diverse classifications and numerous associated genes, proteins, and microRNAs.
  • Currently, epilepsy-associated data is fragmented across various public repositories, hindering comprehensive research.
  • Existing anti-epileptic drugs (AEDs) target specific proteins, but a unified resource for exploring these targets is lacking.

Purpose of the Study:

  • To develop a centralized platform for epilepsy research data integration.
  • To provide tools for analyzing epilepsy-associated proteins and predicting drug-target interactions.
  • To facilitate the study of anti-epileptic drug (AED) targets within the epilepsy research community.

Main Methods:

  • Utilized text mining to extract epilepsy-associated data from multiple biological sources.
  • Curated and integrated extracted data into an in-house developed epilepsy database.
  • Developed in-house machine learning models to predict protein druggability based on significant protein features.

Main Results:

  • Epilepsy-associated data is now accessible via a web browser interface.
  • The platform displays feature values for proteins of interest.
  • Machine learning model results are presented as visualization plots for enhanced data interpretation.

Conclusions:

  • TREADS (Epilepsy Research Platform) offers a unified database and machine learning tool for the epilepsy research community.
  • The platform aims to streamline the study of anti-epileptic drug targets.
  • TREADS provides a valuable resource for advancing epilepsy research and drug discovery.